XML 16 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2025
Dec. 31, 2024
ASSETS    
Cash and equivalents $ 668 $ 623
Restricted cash 3 3
Accounts receivable, net 621 578
Inventories, net 296 283
Other current assets 135 109
Total current assets 1,723 1,596
Property and equipment, net 485 452
Intangible assets, net 224 152
Right-of-use assets 128 100
Investments in non-consolidated affiliates 25 27
Other non-current assets 163 94
Total assets 3,192 2,862
LIABILITIES AND EQUITY    
Short-term debt 18 18
Accounts payable 557 505
Accrued employee liabilities 88 107
Current lease liability 21 29
Other current liabilities 237 257
Total current liabilities 921 916
Long-term debt, net 292 301
Employee benefits 115 127
Non-current lease liability 111 78
Deferred tax liabilities 62 43
Other non-current liabilities 193 87
Stockholders’ equity:    
Preferred stock (par value 0.01, 50 million shares authorized, none outstanding as of June 30, 2025 and December 31, 2024) $ 0 $ 0
Common stock, shares, outstanding (in shares) 27.3 27.2
Common stock, shares, issued (in shares) 55.0  
Common stock, shares authorized (in shares) 250.0  
Common stock, par value (in dollars per share) $ 0.01  
Common stock (par value $0.01, 250 million shares authorized, 55 million shares issued, 27300000 million shares outstanding as of June 30, 2025 and 27.2 million shares outstanding as of December 31, 2024, respectively) $ 1 $ 1
Additional paid-in capital 1,378 1,376
Retained earnings 2,678 2,548
Accumulated other comprehensive loss (255) (306)
Treasury stock (2,380) (2,390)
Total Visteon Corporation stockholders’ equity 1,422 1,229
Non-controlling interests 76 81
Total equity 1,498 1,310
Total liabilities and equity 3,192 2,862
Deferred Tax Assets, Tax Deferred Expense $ 444 $ 441